ArticleInternational journal of molecular sciences2024

Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models.

Razia Aslam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.